Skip to main content

Table 1 General characters of these 31 hepatoblastoma patients

From: Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma

  Study population (n = 31)
Diagnostic age, medium (IQR), years 1.0 (0.75–2.00)
Male gender, n (%) 19 (61.29%)
Histology, n (%)  
Epithelial type 23 (74.19%)
Fetal pattern 14 (45.16%)
Embryonal pattern 6 (19.35%)
Mixed fetal and embryonal pattern 3 (9.68%)
Small cell undifferentiated / anaplastic pattern 0 (0%)
Mixed Epithelial / Mesenchymal Type 8 (25.81%)
Initial maximal tumor diameter, medium (IQR), cm 9.50 (8.0–12.3)
Alpha-fetoprotein level at diagnosis, medium (IQR), log10 ng/mL 5.09 (4.53–5.76)
Maximal tumor diameter after neo-adjuvant chemotherapy, medium (IQR), cm 5 (4.0–8.2)
Alpha-fetoprotein level after neo-adjuvant chemotherapy, medium (IQR), log10 ng/mL 2.06 (1.45–3.08)
Follow up duration, medium (IQR), years 5.11 (2.97–7.16)
Mortality, n (%) 7 (22.58%)
Liver transplantation, n (%) 3 (9.68%)
Survival with native liver, n (%) 22 (70.97%)
Tumor recurrence after tumor resection, n (%) 8 (25.81%)
PRETEXT stage, n (%)  
PRETEXT I 1 (3.22%)
PRETEXT II 13 (41.94%)
PRETEXT III 10 (32.26%)
PRETEXT IV 7 (22.58%)
  1. IQR, interquartile range; PRETEXT, PRETreatment EXTent of disease